Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Pediatric Nephrology
Published in: Pediatric Nephrology 7/2012

01-07-2012 | Educational Review

Understanding renal posttransplantation anemia in the pediatric population

Authors: Paul Joseph Galutira, Marcela Del Rio

Published in: Pediatric Nephrology | Issue 7/2012

Login to get access

Abstract

Advances in renal transplantation management have proven to be beneficial in improving graft and patient survival. One of the properties of a well-functioning renal allograft is the secretion of adequate amounts of the hormone erythropoietin to stimulate erythropoiesis. Posttransplantation anemia (PTA) may occur at any point in time following transplantation, and the cause is multifactoral. Much of our understanding of PTA is based on studies of adult transplant recipients. The limited number of studies that have been reported on pediatric renal transplant patients appear to indicate that PTA is prevalent in this patient population. Erythropoietin deficiency or resistance is commonly associated with iron deficiency. An understanding of the risk factors, pathophysiology and management of PTA in the pediatric renal transplant population may provide guidelines for clinicians and researchers in the pursuit of larger prospective randomized control studies aimed at improving our limited knowledge of PTA. Recognition of PTA through regular screening and evaluation of the multiple factors that may contribute to its development are recommended after transplantation.
Literature
1.
Kawada N, Moriyama T, Icimaru N, Imamura R, Matsui I, Takabatake Y, Nagasawa Y, Isaka Y, Kojima Y, Kokado Y, Rakugi H, Imai E, Takahara S (2009) Negative effects of anemia on quality of life and its improvement by complete correction of anemia by administration of recombinant human erythropoietin in posttransplant patients. Clin Exp Nephrol 13:355–360PubMedCrossRef
2.
Gheith O, Wafa E, Hassan N, Mostafa A, Sheshaa H, Mahmoud K, Shokeir A, Ghoneim M (2009) Does posttransplant anemia at 6 months affect long-term outcome of live-donor kidney transplantation? A single-center experience. Clin Exp Nephrol 13:361–366PubMedCrossRef
3.
Imoagene-Oyedeji AE, Rosas SE, Doyle AM, Goral S, Bloom RD (2006) Posttransplantation anemia at 12 months in kidney recipients treated with mycophenolate mofetil: risk factors and implications for mortality. J Am Soc Nephrol 17:3240–3247PubMedCrossRef
4.
Rigatto C, Foley R, Jeffrey J, Negrijn C, Tribula C, Parfrey P (2003) Electrocardiographic left ventricular hypertrophy in renal transplant recipients: prognostic value and impact of blood pressure and anemia. J Am Soc Nephrol 14:462–468PubMedCrossRef
5.
Kasiske BL, Vazquez MA, Harmon WE, Brown RS, Danovitch GM, Gaston RS, Roth D, Scandling JD Jr, Singer GG (2000) Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol 11[Suppl 15]:S1–S86PubMed
6.
Turkowski-Duhem A, Kamar N, Cointault O, Lavaysierre L, Ribes D, Esposito L, Fillola G, Durand D, Rostaing L (2005) Predictive factors of anemia within the first year post renal transplant. Transplantation 80:903–909PubMedCrossRef
7.
Yorgin P, Belson A, Sanchez J, Al Uzri A, Sarwal M, Bloch D, Oehlert J, Salvatierra O, Alexander S (2002) Unexpectedly high prevalence of posttransplant anemia in pediatric and young adult renal transplant recipients. Am J Kidney Dis 40:1306–1318PubMedCrossRef
8.
Mitsnefes M, Subat-Dezulovic M, Khoury P, Goebel J, Strife CF (2005) Increasing incidence of post-kidney transplant anemia in children. Am J Transplant 5:1713–1718PubMedCrossRef
9.
National Kidney Foundation (NKF), Kidney Disease Outcomes Quality Initiative (KDOQI) (2001) clinical practice guidelines for anemia of chronic kidney disease (2000). Am J Kidney Dis 37:S182–S238CrossRef
10.
Kausman J, Powell H, Jones C (2004) Anemia in pediatric renal transplant patients. Pediatr Nephrol 19:526–530PubMedCrossRef
11.
Vanrenterghem Y, Ponticelli C, Morales JM, Abramowicz D, Baboolal K, Eklund B, Kliem V, Legendre C, Sarmento AL, Vincenti F (2003) Prevalence and management of anemia in renal transplant recipients: a European survey. Am J Transplant 3:835–845PubMedCrossRef
12.
Lorenz M, Kletzmayr J, Perschl A, Furrer A, Horl W, Sunder-Plassmann G (2002) Anemia and iron deficiencies among long-term renal transplant recipients. J Am Soc Nephrol 13:794–797PubMed
13.
Saito S, Fujiwara T, Sakagami K, Matsuno T, Tanaka N (1998) Anemia following renal transplantation. Transplant Proc 30:3025–3026PubMedCrossRef
14.
Miles AM, Markell MS, Daskalakis P, Sumrani NB, Hong J, Sommer BJ, Friedman EA (1997) Anemia following renal transplantation: erythropoietin response and iron deficiency. Clin Transplant 11:313–315PubMed
15.
Molnar MZ, Novak M, Ambrus C, Kovacs A, Pap J, Remport A, Szeifert L, Mucsi I (2005) Anemia in kidney transplanted patients. Clin Transplant 19:825–833PubMedCrossRef
16.
Ghafari A, Noori-Majelan N (2008) Anemia among long-term renal transplant recipients. Transplant Proc 40:186–188PubMedCrossRef
17.
Ott U, Busch M, Steiner T (2008) Anemia after renal transplantation: an underestimated problem. Transplant Proc 40:3481–3484PubMedCrossRef
18.
Peter C, Latta K, Graf D, Offner G, Brodehl J (1998) Does tacrolimus cause more severe anemia than cyclosporine A in children after renal transplantation? Transpl Int 11[Suppl 1]:S328–S330PubMed
19.
Karakus S, Kanbay M, Koseoglu HK, Colak T, Haberal M (2004) Causes of anemia in renal transplant recipients. Transplant Proc 36:164–165PubMedCrossRef
20.
Shah N, Al-Khoury S, Afzali B, Covic A, Roche A, Marsh J, McDougall IC, Goldsmith DJ (2006) Posttransplantation anemia in adult renal allograft recipients: prevalence and predictors. Transplantation 81:1112–1118PubMedCrossRef
21.
Unal A, Sipahioglu MH, Akcakaya B, Tokgoz B, Sav T, Omyak O, Utas C (2008) An underappreciated problem in renal transplant recipients: anemia. Transplant Proc 40:1399–1403PubMedCrossRef
22.
Chua MS, Barry C, Chen X, Salvatierra O, Sarwal MM (2003) Molecular profiling of anemia in acute renal allograft rejection using DNA microarrays. Am J Transplant 3(1):17–22PubMedCrossRef
23.
Nampoory MRN, Johny KV, Al-Hilalin SMS, Kanagasabhapathy AS (1996) Erythropoietin deficiency and relative resistance cause anemia in post-renal transplant patients with normal renal function. Nephrol Dial Transplant 11:177–181PubMedCrossRef
24.
Khosroshahi HT, Shoja MM, Tubbs RS, Estakhri R, Adralan MR (2007) Serum erythropoietin levels and their correlation with the erythropoietic system in hemodialysis patients and renal allograft recipients. Transplant Proc 39:1051–1053PubMedCrossRef
25.
Abbud-Filho M, Adams P, Alberu J, Cardella C, Chapman J, Cochat P, Cosio F, Danovitch G, Davis C, Gaston R, Humar A, Hunsicker L, Josephson M, Kasiske B, Kirste G, Leichtman A, Munn S, Obrador G, Tibell A, Wadstrom J, Zeier M, Delmonico F (2007) A report of the Lisbon Conference on the care of the kidney transplant recipient. Transplantation 83:S1–S22PubMedCrossRef
26.
Geetha D, Zachary JB, Baldado HM, Kronz JD, Kraus ES (2000) Pure red cell aplasia caused by Parvovirus B19 infection in solid organ transplant recipients: a case report and review of literature. Clin Transplant 14:586–591PubMedCrossRef
27.
Garewal G, Ahluwalia J, Varma N, Das R, Sakhuja VK (2004) Parvovirus B19 infection-associated red- cell aplasia in renal-transplant recipients: clues from the bone marrow. Transplantation 77:320–321PubMedCrossRef
28.
Reddehase MJ, Dreher-Stumpp L, Angele P, Balthesen M, Susa M (1992) Hematopoietic stem cell deficiency resulting from cytomegalovirus infection of bone marrow stroma. Ann Hematol 64:A125PubMedCrossRef
29.
Almeida-Porada GD, Ascensao JL (1996) Cytomegalovirus as a cause of pancytopenia. Leuk Lymphoma 21:217PubMedCrossRef
30.
Mix TC, Kazmi W, Khan S, Ruthazer R, Rohrer R, Pereira BJ, Kausz AT (2003) Anemia: A continuing problem following kidney transplantation. Am J Transplant 3:1426–1433PubMedCrossRef
31.
Van Loo A, Vanholder R, Bernaert P, De Rose J, Lameire N (1996) Recombinant human erythropoietin corrects anemia during the first few weeks after renal transplantation: a randomized prospective study. Nephrol Dial Transplant 11:1815–1821PubMedCrossRef
32.
Vlahakos DV, Canzanello VJ, Madaio MP, Madias NE (1991) Enalapril-associated anemia in renal transplant recipients treated for hypertension. Am J Kidney Dis 17:199–205PubMed
33.
Pagel H, Jelkmann W, Weiss C (1988) A comparison of the effects of renal artery constriction and anemia on the production of erythropoietin. Pflugers Arch 413:62–66PubMedCrossRef
34.
Gossman J, Thurman P, Bachmann T, Weller S, Kachel HG, Schoeppe W, Scheuermann EH (1996) Mechanism of angiotensin converting enzyme inhibitor-related anemia in renal transplant recipients. Kidney Int 50:9730978CrossRef
35.
Gossman J, Kachel HG, Schoeppe W, Scheuermann EH (1993) Anemia in renal transplant recipients caused by concomitant therapy with azathioprine and angiotensin converting enzyme inhibitors. Transplantation 56:585–589CrossRef
36.
Tornero F, Prats D, Alvarez-Sala JL, Coronel F, Sanchez A, Barrientos A (1993) Iron deficiency anemia after successful renal transplantation. J Urol 149:1398–1400PubMed
37.
Besarab A, Caro J, Jarrell BE, Francos G, Erslev AJ (1987) Dynamics of erythropoiesis following renal transplantation. Kidney Int 32:526–536PubMedCrossRef
38.
Soh S, Kumano K, Utsunomiya T, Mashimo S, Endo T (1994) Serum erythropoietin levels after renal transplantation. Transplant Proc 26:2154–2156PubMed
39.
Brown J, Lappin T, Elfer G, Taylor T, Bridges J, McGeown M (1989) The initiation of erythropoiesis following renal transplantation. Nephrol Dial Transplant 4:1076–1079PubMed
40.
Kessler M (1995) Erythropoietin and erythropoiesis in renal transplantation. Nephrol Dial Transplant 10:114–116PubMed
41.
Van Loo A, Vanholder R, Bernaert P, De Roose J, Lameire N (1996) Recombinant human erythropoietin coorects anemia during the first weeks after renal transplantation: a randomized prospective study. Nephrol Dial Transplant 11:1815–1821PubMedCrossRef
42.
Schaeffer R, Schaeffer L (1999) Evaluation of iron status in renal failure patients. Kidney Int 55[Suppl 69]:S44–S48CrossRef
43.
Wish J (2006) Assessing iron status: beyond serum ferritin and transferring saturation. Clin J Am Soc Nephrol 1:S4–S8PubMedCrossRef
44.
Al-Uzri A, Yorgin P, Kling P (2003) Anemia in children after transplantation: etiology and the effect of immunosuppressive therapy on erythropoiesis. Pediatr Transplant 7:253–264PubMedCrossRef
45.
EBPG Expert Group on Renal Transplantation (2002) European best practice guidelines for renal transplantation. Section IV: long-term management of the transplant recipient. IV.9.1. Haematological complications. Nephrol Dial Transplant 17(Suppl 4):48
46.
47.
Van Damme-Lombaerts R, Herman J (1999) Erythropoietin treatment in children with renal failure. Pediatr Nephrol 13:148–152PubMedCrossRef
48.
Schroder CH, European Pediatric Peritoneal Dialysis Working Group (2003) The management of anemia in pediatric peritoneal dialysis patients. Guidelines by an ad hoc European committee. Pediatr Nephrol 18:805–809PubMedCrossRef
49.
Fishbane S, Kowalski EA (2000) The comparative safety of intravenous iron dextran, iron saccharate, and sodium ferric gluconate. Semin Dial 13(6):381–384PubMedCrossRef
50.
Warady BA, Kausz A, Lerner G, Brewer ED, Chadha V, Brugnara C, Dahl NV, Watkins SL (2004) Iron therapy in the pediatric hemodialysis population. Pediatr Nephrol 19:655661
51.
Warady BA, Zobrist R, Wu J, Finan E, Ferrlecit Pediatric Study Group (2005) Sodium ferric gluconate complex therapy in anemic children on hemodialysis. Pediatr Nephrol 20:1320–1327PubMedCrossRef
52.
Warady BA, Zobrist R, Finan E, Ferrlecit Pediatric Study Group (2006) Sodium ferric gluconate complex maintenance therapy in children on hemodialysis. Pediatr Nephrol 21:553–560PubMedCrossRef
53.
Michael B, Coyne D, Fishbane S, Folkert V, Lynn R, Nissenson A, Agarwal R, Eschbach J, Fadem S, Trout JR, Strobos J, Ferrlecit WD, Committee P (2002) Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran. Kidney Int 61:1830–1839PubMedCrossRef
54.
Faich G, Strobos J (1999) Sodium ferric gluconate complex in sucrose: safer intravenous iron therapy than iron dextrans. Am J Kidney Dis 33:464–470PubMedCrossRef
55.
Novey HS, Pahl M, Haydik I, Vaziri ND (1994) Immunologic studies of anaphylaxis to iron dextran in patients on renal dialysis. Ann Allergy 72:224–228PubMed
56.
Gillespie R, Symons J (2005) Sodium ferric gluconate for post-transplant anemia in pediatric and young adult renal transplant recipients. Pediatr Transplant 9:43PubMedCrossRef
57.
Yorgin P (2005) Intravenous iron therapy in pediatric transplant recipients: What do we really know? Pediatr Transplant 9:1–3PubMed
58.
Institute of Medicine. Food and Nutrition Board (2001) Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium and zinc. National Academy Press, Washington, DC
59.
Blumberg N, Heal JM (1996) Immunomodulation by blood transfusion: An evolving scientific and clinical challenge. Am J Med 101:299PubMedCrossRef
60.
Eikmans M, Waanders MM, Roelen DL, van Miert PP, Anholts J, de Fijter HW, Brand A, Claas F (2010) Differential effect of pretransplant blood transfusions on immune effector and regulatory compartments in HLA-sensitized and nonsensitized recipients. Transplantation 90:1192–1199PubMedCrossRef
Metadata
Title
Understanding renal posttransplantation anemia in the pediatric population
Authors
Paul Joseph Galutira
Marcela Del Rio
Publication date
01-07-2012
Publisher
Springer-Verlag
Published in
Pediatric Nephrology / Issue 7/2012
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-011-2036-1

Other articles of this Issue 7/2012

Pediatric Nephrology 7/2012 Go to the issue

Original Article

Natural history of bilateral mild isolated antenatal hydronephrosis conservatively managed

Review

Acute tubulointerstitial nephritis

Original Article

Early cardiac dysfunction in pediatric patients on maintenance dialysis and post kidney transplant

Brief Report

Alport-like glomerular basement membrane changes with renal-coloboma syndrome

Brief Report

Boy with autosomal recessive polycystic kidney and autosomal dominant polycystic liver disease

Review

Glucocorticoid-induced hypertension